RF-assisted Splenic Preservation VS Conventional Treatment of Blunt Splenic Injury.
NCT ID: NCT03890328
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2009-03-01
2014-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A total of 122 patients with splenic trauma admitted to two tertiary referral centers from June 2011 to June 2014 were included in this prospective cohort study. The 67 patients at one center were treated by radiofrequency-assisted spleen-preserving therapy (RF group), and the 55 patients admitted at the other center underwent conventional treatment (CT group). Demographics and clinical characteristics of the two groups were comparable.
Compared to traditional splenorrhaphy and splenectomy, RF-assisted splenic hemostasis and salvage was safe, effective and easy to use in the treatment of splenic injuries. In particular for high-grade splenic injuries, these techniques preserved sufficient splenic tissue without any increase in patients with surgical risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome After Conservative and Surgical Treatment of Splenic Injuries After Blunt Abdominal Trauma.
NCT00910182
Laparoscopic Splenectomy in Isolated High Grades Splenic Injuries
NCT04329845
Observation vs Embolization in Severe Splenic Injury: A Randomized Controlled Trial
NCT05008172
Treatment of Splenic Trauma: a Retrospective Cohort Study
NCT01965548
Non-traumatic Rupture of the Spleen. Can Splenectomy be Applied Selectively?
NCT01845662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RF group
radiofrequency-assisted spleen-preserving therapy group.
radiofrequency ablation
apply RF therapy to the treatment of splenic trauma
CT group
Conventional Treatment of Blunt Splenic Injury group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiofrequency ablation
apply RF therapy to the treatment of splenic trauma
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. blunt abdominal injury combined with indication of post-traumatic splenectomy according to the guidelines provided by the Society for Surgery of the Alimentary Tract in 2005
3. patients transferred directly to the trauma center after injury who had not been treated by any specific spleen-directed therapy in the transferring hospital
4. AAST grade II splenic injury with hemodynamic instability or progressive bleeding requiring active intervention
5. AAST grade Ⅲ-Ⅳsplenic injury, or splenic laceration involving less than 50% of the splenic parenchyma
Exclusion Criteria
2. concomitant organ injury with an abbreviated injury scale (AIS) greater than 4 that threatened the life of the patient
3. excessive vascular injury to the splenic pedicle or substantial devitalized splenic tissues when it was expected in when less than 25% of the spleen could be preserved
4. patients who had failed NOM
5. patients with pathologic splenic rupture
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West China Second University Hospital
OTHER
Southwest Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
fengkai
associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kuansheng Ma, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Institute of hepatobiliary surgery,Southwest Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of hepatobiliary surgery,Southwest Hospital
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
81672857
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.